MedKoo Cat#: 463661 | Name: SP10
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SP10 is a novel highly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction.

Chemical Structure

SP10
SP10
CAS#882157-88-2

Theoretical Analysis

MedKoo Cat#: 463661

Name: SP10

CAS#: 882157-88-2

Chemical Formula: C56H94N14O20S

Exact Mass: 1314.6490

Molecular Weight: 1315.51

Elemental Analysis: C, 51.13; H, 7.20; N, 14.91; O, 24.32; S, 2.44

Price and Availability

Size Price Availability Quantity
1mg USD 500.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SP10; SP 10; SP-10; SP-10 (residues 668–679); SP10 (residues 668–679); SP 10 (residues 668–679);
IUPAC/Chemical Name
L-seryl-L-threonyl-L-seryl-L-glutaminyl-L-lysyl-L-seryl-L-isoleucyl-L-valyl-L-alanyl-L-tyrosyl-L-threonyl-L-methionine
InChi Key
RBLTWUZIFRZOSV-SQWMWQRLSA-N
InChi Code
InChI=1S/C56H94N14O20S/c1-9-27(4)42(53(86)67-41(26(2)3)52(85)60-28(5)45(78)64-37(22-31-13-15-32(76)16-14-31)49(82)70-44(30(7)75)54(87)63-36(56(89)90)19-21-91-8)68-51(84)39(25-73)65-47(80)34(12-10-11-20-57)61-48(81)35(17-18-40(59)77)62-50(83)38(24-72)66-55(88)43(29(6)74)69-46(79)33(58)23-71/h13-16,26-30,33-39,41-44,71-76H,9-12,17-25,57-58H2,1-8H3,(H2,59,77)(H,60,85)(H,61,81)(H,62,83)(H,63,87)(H,64,78)(H,65,80)(H,66,88)(H,67,86)(H,68,84)(H,69,79)(H,70,82)(H,89,90)/t27-,28-,29+,30+,33-,34-,35-,36-,37-,38-,39-,41-,42-,43-,44-/m0/s1
SMILES Code
O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCSC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
SP10 is a small peptide derived from S protein with an IC50 value of 1.88 nM for blocks the interaction between S protein and ACE2.
In vitro activity:
SP10 has therapeutic potential for the treatment of SARS-CoV infections. SP10 significantly blocked the interaction between S protein and ACE2 by biotinylated enzyme-linked immunosorbent assay with an IC50 value of 1.88 +/- 0.52 nmol. SP10 blocked both binding of the S protein and infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. Reference: Antiviral Res. 2006 Feb;69(2):70-6. https://pubmed.ncbi.nlm.nih.gov/16337697/
In vivo activity:
To be determined

Preparing Stock Solutions

The following data is based on the product molecular weight 1,315.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2006 Feb;69(2):70-6. doi: 10.1016/j.antiviral.2005.10.005. Epub 2005 Nov 28. PMID: 16337697; PMCID: PMC7114127.
In vitro protocol:
1. Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2006 Feb;69(2):70-6. doi: 10.1016/j.antiviral.2005.10.005. Epub 2005 Nov 28. PMID: 16337697; PMCID: PMC7114127.
In vivo protocol:
To be determined